Company Monitoring Page for Astellas

latest headlines for company on cafepharma

Pfizer, Astellas rocket toward broader Xtandi use with FDA 'priority' tag
Fierce Pharma
Thu, 08/22/19 - 11:56 am
Tags:
Pfizer, Astellas, Xtandi, prostate cancer, FDA, priority review
Astellas tests gamification ideas with Japanese universities
Pharmaforum
Thu, 08/15/19 - 10:45 am
Tags:
Astellas, Japan, gamification
Astellas pushes non-hormonal menopause drug into phase 3
Pharmaforum
Wed, 08/7/19 - 11:48 pm
Tags:
Astellas, menopause, clinical trials, fezolinetant
Frequency bags $62M to advance Astellas-partnered hearing loss drug
Fierce Biotech
Tue, 07/23/19 - 10:10 am
Tags:
Frequency Therapeutics, hearing loss, Astellas, FX-322
On heels of trial readout, Frequency out-licenses hearing loss therapy to Astellas
BioCentury
Wed, 07/17/19 - 10:46 am
Tags:
Frequency Therapeutics, hearing loss, FX-322, Astellas
Why pharma needs honest patient dialogue
Pharmaforum
Sat, 07/13/19 - 11:14 am
Tags:
Astellas, drug pricing, patients
ASCO: Pfizer, Astellas' Xtandi racks up more data for new prostate cancer approval
Fierce Pharma
Sun, 06/2/19 - 01:17 pm
Tags:
Pfizer, Astellas, Xtandi, prostate cancer, ASCO 2019
Feds say Astellas, Amgen will fork over $125M to settle charity kickback probes
Fierce Pharma
Thu, 04/25/19 - 06:49 pm
Tags:
Astellas, Amgen, kickbacks, charity, DOJ
Xencor, Astellas Pharma collaborate on novel bispecific antibody program
Pharmaceutical Business Review
Wed, 04/3/19 - 10:00 am
Tags:
Xencor, Astellas, R&D, bispecific antibodies
AACR: Astellas pads Xospata's AML lead with chemo-beating survival data
Fierce Pharma
Mon, 04/1/19 - 12:38 pm
Tags:
Astellas, Xospata, acute myeloid leukemia, AML, AACR
Key bladder cancer data pave way for Seattle Genetics to submit marketing application for armed antibody
Endpoints
Thu, 03/28/19 - 10:10 am
Tags:
Seattle Genetics, Astellas, enfortumab vedotin, bladder cancer
Bayer files prostate cancer drug darolutamide in Japan
Pharmaforum
Tue, 03/5/19 - 10:02 am
Tags:
Bayer, prostate cancer, darolutamide, Japan, JNJ, Pfizer, Astellas
Pfizer, Astellas chase new Xtandi nod with big survival numbers in prostate cancer
Fierce Pharma
Tue, 02/12/19 - 12:01 pm
Tags:
Xtandi, Astellas, Pfizer, hormone-sensitive prostate cancer
Astellas and Pfizer's Xtandi Meets Primary Endpoint in Ph III Trial of Metastatic Prostate Cancer
CP Wire
Thu, 12/20/18 - 10:27 am
Tags:
Astellas, Pfizer, Xtandi, prostate cancer, metastatic prostate cancer
Thu, 12/20/18 - 10:19 am
Tags:
Astellas, Pfizer, Xtandi, prostate cancer, metastatic prostate cancer
Astellas gains three cancer drugs with $405m Potenza buy
Pharmaforum
Fri, 12/14/18 - 12:47 pm
Tags:
Astellas, Potenza Therapeutics, M&A, cancer immunotherapy
FDA stamps fast OK on Astellas' pioneering FLT3 AML drug gilteritinib, expanding on a record year for new approvals
Endpoints
Thu, 11/29/18 - 12:10 am
Tags:
Astellas, FDA, AML, Xospata, gilteritinib
Pharma/Biotech Stocks to Watch This Prostate Cancer Month
Yahoo/Zacks.com
Sun, 09/16/18 - 02:16 pm
Tags:
prostate cancer, JNJ, Zytiga, Erleada, Pfizer, Astellas, Xtandi, AbbVie, Lupron, Endocyte, Lu-PSMA-617
Pfizer, Astellas revise two cancer drug trial protocols to speed up results
Yahoo/Reuters
Wed, 08/22/18 - 06:05 pm
Tags:
Pfizer, Astellas, clinical trials, Xtandi, prostate cancer
Linzess Receives Additional Indication in Japan for Chronic Constipation
CP Wire
Tue, 08/21/18 - 10:05 am
Tags:
Linzess, Astellas, Ironwood, chronic constipation

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.